Please try another search
Plumbline Life Sciences, Inc. engages in the development and sale of DNA medicines for animals. Its products include LifeTide SW5, a pig immune-modulator; PLS-ASF, a swine fever DNA vaccine; PLS-FMD; PLS-B3000, a dairy cattle DNA therapy; PLS-IF1000, a FMD vaccine; PLS-H1000, a horse laminitis therapy; PLS-D5000, a dog DNA cancer immunotherapy; PLS-D1000 for age related immune deficiency in senior dogs; and PLS-C2000 for age related immune deficiency in senior cats. Plumbline Life Sciences, Inc. was founded in 2014 and is headquartered in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Anthony K. Kim | - | - | President, CEO & Director |
Yong-Ho Park | 69 | - | Member of Veterinary Advisory Board |
Yong Pal Kim | - | 2020 | Member of Veterinary Advisory Board |
David B. Weiner | 68 | - | Chief of Veterinary Advisory Board |
Sang Joon Lee | - | 2020 | Independent Outside Director |
Sung Dae Jung | - | - | Member of Veterinary Advisory Board |
Jae Bong Moon | - | - | Member of Veterinary Advisory Board |
Jungul Choi | - | 2021 | Auditor & Director |
Joo Hyun Kim | - | - | Independent Director |
Eun Jin Kim | - | 2022 | Director & CSDO |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review